Dermbiont
Boston, United States · Founded 2017 · $71.2M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- dermbiont.com
- Total Funding
- $71.2M
- Last Round
- $35.2M Series BOct 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Precision dermatology biotech developing and commercializing targeted topical therapeutics for skin diseases.
Summary
Dermbiont is a Biotech company based in Boston, United States, founded in 2017. It has raised $71.2M in total across 3 rounds, most recently a $35.2M Series B round in Oct 2023. Investors include Viking Global, Olive Tree Capital and Toba Capital.
Funding History
Oct 2023
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dermbiont"><img src="https://indexed.vc/api/badge/company/dermbiont" alt="Dermbiont on Indexed.vc" width="260" height="76" /></a>